Talat Imran insider trades
Open-market stock purchases and sales by Talat Imran, Chief Executive Officer at Rani Therapeutics Holdings, Inc, from SEC Form 4 filings since Sep 9, 2021.
Track record: 17% of 6 scored buys are up 5% or more since purchase, averaging -52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 17, 2026 | RANI Rani Therapeutics Holdings, Inc | Bought | $25.2K |
| Jun 27, 2026 | RANI Rani Therapeutics Holdings, Inc | Sold (not open market) | $5.9K |
| Jun 3, 2026 | RANI Rani Therapeutics Holdings, Inc | Bought (not open market) | — |
| Mar 27, 2026 | RANI Rani Therapeutics Holdings, Inc | Sold (not open market) | $7.4K |
| Mar 22, 2026 | RANI Rani Therapeutics Holdings, Inc | Sold (not open market) | $10.1K |
| Dec 27, 2025 | RANI Rani Therapeutics Holdings, Inc | Sold (not open market) | $11.1K |
Companies traded
- RANI Rani Therapeutics Holdings, Inc: 6 buys, 1 sale, last Jul 17, 2026